- Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia2015 | Publication without faculty affiliation
- A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL2016 | Faculty of Medicine in Hradec Králové
- Chemoimmunotherapy with O-FC previously untreated patients with chronic lymphocytic leukemia2011 | Faculty of Medicine in Hradec Králové
- Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma2012 | Faculty of Medicine in Hradec Kr álové
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis A phase 2 study2014 | First Faculty of Medicine